Calidi Biotherapeutics Files 8-K
Ticker: CLDWW · Form: 8-K · Filed: Jul 5, 2024 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Jul 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, regulatory
Related Tickers: CLDI
TL;DR
Calidi Biotherapeutics filed an 8-K on July 5, 2024, updating its status and financials.
AI Summary
On July 5, 2024, Calidi Biotherapeutics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD disclosures and financial statements/exhibits. It also notes the company's former name was First Light Acquisition Group, Inc., with a name change effective April 6, 2021.
Why It Matters
This 8-K filing provides important updates and disclosures for Calidi Biotherapeutics, Inc., which may impact investor understanding of the company's regulatory compliance and financial reporting.
Risk Assessment
Risk Level: low — This filing is a routine disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- First Light Acquisition Group, Inc. (company) — Former company name
- July 5, 2024 (date) — Date of earliest event reported
- April 6, 2021 (date) — Date of name change
FAQ
What is the primary purpose of this 8-K filing for Calidi Biotherapeutics, Inc.?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What was Calidi Biotherapeutics, Inc.'s former name?
Calidi Biotherapeutics, Inc.'s former name was First Light Acquisition Group, Inc.
When did the company change its name from First Light Acquisition Group, Inc.?
The company's name change from First Light Acquisition Group, Inc. was effective on April 6, 2021.
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing is July 5, 2024.
In which state is Calidi Biotherapeutics, Inc. incorporated?
Calidi Biotherapeutics, Inc. is incorporated in Delaware.
Filing Stats: 517 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2024-07-05 16:30:20
Key Financial Figures
- $0.0001 — ch Registered Common stock, par value $0.0001 per share CLDI NYSE American LLC
Filing Documents
- form8-k.htm (8-K) — 42KB
- ex99-1.htm (EX-99.1) — 16KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001493152-24-026374.txt ( ) — 281KB
- cldi-20240705.xsd (EX-101.SCH) — 4KB
- cldi-20240705_def.xml (EX-101.DEF) — 26KB
- cldi-20240705_lab.xml (EX-101.LAB) — 36KB
- cldi-20240705_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CALIDI BIOTHERAPEUTICS, INC. Dated: July 5, 2024 By: /s/ Andrew Jackson Name: Andrew Jackson Title: Chief Financial Officer